As of 2025-11-28, the EV/EBITDA ratio of Aerie Pharmaceuticals Inc (AERI) is -58.69. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Aerie's latest enterprise value is 1,012.11 mil USD. Aerie's TTM EBITDA according to its financial statements is -17.25 mil USD. Dividing these 2 quantities gives us the above Aerie EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.4x - 17.0x | 16.7x |
| Forward P/E multiples | 15.0x - 16.4x | 15.4x |
| Fair Price | (10.61) - (10.97) | (10.83) |
| Upside | -169.6% - -171.9% | -171.0% |
| Date | EV/EBITDA |